These results highlight the importance of a largely overlooked transcription factor in the progression and metastasis of melanoma, and show that induction of BRN2 expression leads to cells gaining a drug-resistant phenotype able to survive under non-adherent conditions. This evidence concerns the gene POU3F2 and melanoma.